Mutations that cause esophageal adenocarcinoma (OAC) have been mapped in unprecedented detail — unveiling that more than half could be targeted by drugs currently in trials for other cancer types
https://www.sciencedaily.com/releases/2019/02/190204114543.htm
Mapping esophageal cancer genes leads to new drug targets